ECS Botanics Holdings Ltd - Asset Resilience Ratio
ECS Botanics Holdings Ltd (ECS) has an Asset Resilience Ratio of 5.07% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1989–2024)
This chart shows how ECS Botanics Holdings Ltd's Asset Resilience Ratio has changed over time. Check ECS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down ECS Botanics Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is ECS Botanics Holdings Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$1.67 Million | 5.07% |
| Total Liquid Assets | AU$1.67 Million | 5.07% |
Asset Resilience Insights
- Limited Liquidity: ECS Botanics Holdings Ltd maintains only 5.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ECS Botanics Holdings Ltd Industry Peers by Asset Resilience Ratio
Compare ECS Botanics Holdings Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621 |
Drug Manufacturers - Specialty & Generic | 2.04% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
|
Jw Pharmac
KO:001060 |
Drug Manufacturers - Specialty & Generic | 3.65% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Samjin Pharm
KO:005500 |
Drug Manufacturers - Specialty & Generic | 0.25% |
Annual Asset Resilience Ratio for ECS Botanics Holdings Ltd (1989–2024)
The table below shows the annual Asset Resilience Ratio data for ECS Botanics Holdings Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 5.07% | AU$1.67 Million ≈ $1.18 Million |
AU$32.88 Million ≈ $23.27 Million |
+1.00pp |
| 2023-06-30 | 4.06% | AU$1.06 Million ≈ $751.34K |
AU$26.13 Million ≈ $18.49 Million |
-8.23pp |
| 2022-06-30 | 12.29% | AU$2.93 Million ≈ $2.07 Million |
AU$23.82 Million ≈ $16.86 Million |
-8.93pp |
| 2021-06-30 | 21.22% | AU$4.24 Million ≈ $3.00 Million |
AU$20.01 Million ≈ $14.16 Million |
-13.61pp |
| 2020-06-30 | 34.83% | AU$1.90 Million ≈ $1.35 Million |
AU$5.47 Million ≈ $3.87 Million |
+10.62pp |
| 2019-06-30 | 24.21% | AU$1.72 Million ≈ $1.22 Million |
AU$7.12 Million ≈ $5.03 Million |
-46.03pp |
| 2001-06-30 | 70.24% | AU$8.52 Million ≈ $6.03 Million |
AU$12.13 Million ≈ $8.58 Million |
+69.95pp |
| 2000-06-30 | 0.29% | AU$50.00K ≈ $35.38K |
AU$17.33 Million ≈ $12.26 Million |
-2.41pp |
| 1996-06-30 | 2.70% | AU$235.65K ≈ $166.74K |
AU$8.73 Million ≈ $6.18 Million |
-11.84pp |
| 1995-06-30 | 14.54% | AU$465.00K ≈ $329.02K |
AU$3.20 Million ≈ $2.26 Million |
+4.02pp |
| 1994-06-30 | 10.52% | AU$620.00K ≈ $438.69K |
AU$5.89 Million ≈ $4.17 Million |
+3.53pp |
| 1993-06-30 | 7.00% | AU$311.00K ≈ $220.05K |
AU$4.45 Million ≈ $3.15 Million |
-5.11pp |
| 1992-06-30 | 12.10% | AU$542.00K ≈ $383.50K |
AU$4.48 Million ≈ $3.17 Million |
+8.75pp |
| 1991-06-30 | 3.35% | AU$140.00K ≈ $99.06K |
AU$4.18 Million ≈ $2.96 Million |
+0.47pp |
| 1990-06-30 | 2.88% | AU$100.00K ≈ $70.76K |
AU$3.47 Million ≈ $2.45 Million |
-7.59pp |
| 1989-06-30 | 10.47% | AU$420.00K ≈ $297.18K |
AU$4.01 Million ≈ $2.84 Million |
-- |
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.